Canterbury DHB



MDS is classified according to the WHO classification, an updated version was published in 2016. Use the updated version to define the specific subtype of MDS and send this information to the New Zealand Cancer Registry (NZCR) for all new diagnoses. See Diagnosis for the diagnostic criteria.

Changes in the 2016 guidelines include:

WHO classification of myeloid neoplasms and acute leukaemia (2016)

Myelodysplastic syndromes (MDS)

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)

About this Canterbury DHB document (4954):

Document Owner:

Emma-Jane McDonald (see Who's Who)

Last Reviewed:

November 2019

Next Review:

November 2021


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 4954